🔎 Trials Near Me

Dachaigh › Glioma › Ohio

Sgrùdaidhean clionaigeach Glioma ann an Ohio

Tha 18 sgrùdaidhean airson Glioma a’ lorg phàirtichean aig làraichean ann an Ohio.

Bailtean ann an Ohio

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Children's Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Rainbow Babies and Childrens Hospital, Cleveland
  • agus 3 a bharrachd
A’ fastadhÌre 1/2
12 Months – 21 Years · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Cleveland Clinic Taussig Cancer Center, Cleveland
  • Ohio State University, Columbus
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Cincinnati Children's Hospital, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 2
12 Months – 39 Years · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06838676

Development of MRF for Characterization of Brain Tumors After Radiotherapy

  • University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
  • Cleveland Clinic Taussig Cancer Center, Cleveland
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06101069

Targeted Pediatric High-Grade Glioma Therapy

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhSgrùdadh amharc
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Cleveland Clinic, Cleveland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05096481

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT05565118

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Nationwide Children's Hospital, Colombus
  • The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
  • Taylor Cancer Research Center, Maumee
A’ fastadhÌre 2
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05503797

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

  • Ohio State University Medical Center, Columbus
A’ fastadh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 21 Iuch 2026 · NCT06910306

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 1/2
Aoisean 4 gu 39 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT05278208

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 2
12 Months – 39 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05843253

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

  • Ohio State University Comprehensive Cancer Center, Columbus
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Cèit 2026 · NCT06964737

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Ohio State University Comprehensive Cancer Center, Columbus
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 1 tràth
Suas gu aois 21 · Gach gnè · Air ùrachadh 18 Màrt 2026 · NCT04655404

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

  • Nationwide Children's Hospital, Columbus
A’ fastadhÌre 1
12 Months – 39 Years · Gach gnè · Air ùrachadh 13 Cèit 2025 · NCT04254419

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.